While 2022 was the second-best year on record for PE investment in healthcare services, dealmaking declined throughout the year and rounded out Q4 at pre-pandemic levels. And PitchBook analysts don’t see a rebound on the horizon quite yet. The staffing crunch, liquidity constraints and a rocky fundraising market will likely continue to drag deal count down in the first half of 2023. The Q4 2022 Healthcare Services Report, sponsored by UnitedHealthcare, breaks down recent PE trends, investment strategies and key regulatory developments in the healthcare services market. The report also spotlights opportunities in rheumatology, value-based care enablers and Medicaid/CHIP pediatric dentistry. Read more.
Related Posts
Growth in Alternate Site Infusion Providers Raises Questions Around Cost of Care and Access
Patient advocates and industry groups have warned against the lack of robust data on the safety and quality of alternate site chemotherapy infusions—particularly home infusion.
June 6, 2023
Medicare Hospital Trust Fund to Run Dry in 2028, Trustees Say
A new report also estimated that Medicare costs will grow faster than the gross domestic product through the late 2070s.
June 6, 2022
East Tennessee Children’s Hospital Reaches $1.55M Settlement in Data Breach
ETCH hasn’t admitted any wrongdoing but agreed to the settlement to resolve the case.
September 8, 2023
Behavioral Health Operators Continue to Face Pushback on New Constructions
Prejudice against those with behavioral health issues, especially substance use disorder (SUD) and those seeking to develop treatment resources for them, is a potent force operators still have to overcome.
June 28, 2023